Figure 3. Dolutegravir and rilpivirine Cmin as compared with the steady-state population PK curves

From

Response to a Dolutegravir-based Regimen in an HIV-Infected Woman with Multiple Comorbidities and a Highly Resistant Strain

Amedeo Capetti, Laura Carenzi, Noemi Astuti, Valeria Cozzi, Valeria Micheli, Maria Vittoria Cossu

American Journal of Medical Case Reports. 2015, 3(7), 201-204 doi:10.12691/ajmcr-3-7-5